W

Willis Towers Watson PLC
NASDAQ:WTW

Watchlist Manager
Willis Towers Watson PLC
NASDAQ:WTW
Watchlist
Price: 318.17 USD -3.6%
Market Cap: $30.5B

Willis Towers Watson PLC
Investor Relations

Willis Towers Watson PLC, a beacon in the realm of professional services, deftly navigates the intricate waters of managing risk, optimizing benefits, and cultivating talent. Formed by the groundbreaking merger of Willis Group and Towers Watson in 2016, the company boasts a robust legacy, synchronizing a wealth of expertise across more than 140 countries. At its core, Willis Towers Watson stands as an architect of solutions designed to enhance organizational performance. Its foundation is built on five critical segments—Human Capital and Benefits; Corporate Risk and Broking; Investment, Risk & Reinsurance; Retirement; and Benefits Delivery & Administration. Each arm functions with a distinct yet interconnected purpose, weaving a comprehensive tapestry that addresses the multifaceted challenges companies face today.

In the competitive world of consulting, Willis Towers Watson derives its revenue by providing tailored expertise and strategic advice. Clients, ranging from small enterprises to global behemoths, seek the company’s counsel to navigate the complexities of employee benefits, manage external financial risk, and streamline essential operations like pension plans. Through meticulous data analysis and industry acumen, the company offers insights that not only mitigate potential threats but also unlock pathways to growth and efficiency. As such, Willis Towers Watson ardently commits to understanding the metrics that drive businesses, striving to blend empirical analysis with human insight. This commitment has established it as an indispensable ally to organizations aiming to harness the full potential of their people and resources.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Feb 3, 2026
AI Summary
Q4 2025

Organic Revenue Growth: WTW delivered 6% organic revenue growth in Q4 and 5% for the full year, hitting its mid-single-digit target.

Margin Expansion: Adjusted operating margin expanded by 130 basis points for the year to 25.2%, with 80 basis points of improvement in Q4.

EPS Growth: Adjusted diluted EPS was $8.12 in Q4 and $17.08 for the year, both up 13% year-over-year when excluding TRANZACT.

Strong Segment Performance: Risk & Broking grew 7% organically in Q4; Health, Wealth & Career saw 6% organic growth and 44.3% operating margin in Q4.

Portfolio Moves: WTW completed the sale of TRANZACT and announced acquisitions of Newfront, Cushon, and FlowStone Partners to optimize its portfolio.

Positive 2026 Outlook: Management reaffirmed mid-single-digit organic growth and continued margin expansion for 2026, supported by strong pipelines and ongoing investments.

Capital Return: $2 billion returned to shareholders in 2025 and at least $1 billion in share repurchases planned for 2026.

Key Financials
Organic Revenue Growth (Q4)
6%
Organic Revenue Growth (Full Year)
5%
Adjusted Operating Margin (Full Year)
25.2%
Adjusted Operating Margin (Q4)
36.9%
Adjusted Diluted EPS (Q4)
$8.12
Adjusted Diluted EPS (Full Year)
$17.08
Health, Wealth & Career Operating Margin (Q4)
44.3%
Risk & Broking Organic Revenue Growth (Q4)
7%
Corporate Risk & Broking Organic Revenue Growth (Q4)
8%
Free Cash Flow (Full Year)
$1.5 billion
Free Cash Flow Margin
15.9%
Capital Returned to Shareholders (Full Year)
$2 billion
Share Repurchases (Q4)
$350 million
Dividends (Q4)
$89 million
Health, Wealth & Career Organic Revenue Growth (Full Year)
4%
BD&O Organic Revenue Growth (Q4)
5%
BD&O Organic Revenue Growth (Full Year)
3%
Tax Rate (Q4)
20.8%
LifeSight Assets Under Management (End of Year)
$46 billion
Other Earnings Calls

Management

Mr. Carl A. Hess CERA, F.S.A.
CEO & Director
No Bio Available
Mr. Adam L. Garrard
Chairman of Risk & Broking
No Bio Available
Ms. Julie Jarecke Gebauer
President of Health, Wealth & Career
No Bio Available
Ms. Alexis Faber
Chief Operating Officer
No Bio Available
Mr. Chris Ford
Global Head of Investment
No Bio Available
Mr. Joseph Stephen Kurpis
Principal Accounting Officer & Controller
No Bio Available
Mr. Eric Arnaldo Latalladi
Global Head of Technology
No Bio Available
Ms. Claudia De La Hoz
Head of Investor Relations
No Bio Available
Ms. Kristy D. Banas
Chief Human Resources Officer, Marketing and Communication
No Bio Available
Mr. Gianmarco Tosti
Head of Corporate Risk & Broking and Italy Country Manager
No Bio Available

Contacts

Address
London
51 Lime Street
Contacts